Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[PDF][PDF] Tumor microenvironment: extracellular matrix alterations influence tumor progression
S Brassart-Pasco, S Brézillon, B Brassart… - Frontiers in …, 2020 - frontiersin.org
The tumor microenvironment (TME) is composed of various cell types embedded in an
altered extracellular matrix (ECM). ECM not only serves as a support for tumor cell but also …
altered extracellular matrix (ECM). ECM not only serves as a support for tumor cell but also …
[HTML][HTML] Collagen remodeling along cancer progression providing a novel opportunity for cancer diagnosis and treatment
K Song, Z Yu, X Zu, G Li, Z Hu, Y Xue - International journal of molecular …, 2022 - mdpi.com
The extracellular matrix (ECM) is a significant factor in cancer progression. Collagens, as the
main component of the ECM, are greatly remodeled alongside cancer development. More …
main component of the ECM, are greatly remodeled alongside cancer development. More …
[HTML][HTML] Collagen family as promising biomarkers and therapeutic targets in cancer
Despite advances in cancer detection and therapy, it has been estimated that the incidence
of cancers will increase, while the mortality rate will continue to remain high, a fact explained …
of cancers will increase, while the mortality rate will continue to remain high, a fact explained …
Collagen VI as a driver and disease biomarker in human fibrosis
L Williams, T Layton, N Yang, M Feldmann… - The FEBS …, 2022 - Wiley Online Library
Fibrosis of visceral organs such as the lungs, heart, kidneys and liver remains a major cause
of morbidity and mortality and is also associated with many other disorders, including cancer …
of morbidity and mortality and is also associated with many other disorders, including cancer …
Targeting tumor-stromal interactions in pancreatic cancer: impact of collagens and mechanical traits
P Maneshi, J Mason, M Dongre… - Frontiers in Cell and …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) has one of the worst outcomes among cancers
with a 5-years survival rate of below 10%. This is a result of late diagnosis and the lack of …
with a 5-years survival rate of below 10%. This is a result of late diagnosis and the lack of …
Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300
LM Williams, FE McCann, MA Cabrita, T Layton… - Proceedings of the …, 2020 - pnas.org
Fibrotic diseases remain a major cause of morbidity and mortality, yet there are few effective
therapies. The underlying pathology of all fibrotic conditions is the activity of myofibroblasts …
therapies. The underlying pathology of all fibrotic conditions is the activity of myofibroblasts …
Endotrophin, a key marker and driver for fibroinflammatory disease
K Henriksen, F Genovese, A Reese-Petersen… - Endocrine …, 2024 - academic.oup.com
Our overview covers several key areas related to recent results obtained for collagen type VI
and endotrophin (ETP).(1) An introduction to the history of ETP, including how it was …
and endotrophin (ETP).(1) An introduction to the history of ETP, including how it was …
[HTML][HTML] Extracellular matrix biomarkers in colorectal cancer
MS Kim, SE Ha, M Wu, H Zogg, CF Ronkon… - International journal of …, 2021 - mdpi.com
The cellular microenvironment composition and changes therein play an extremely
important role in cancer development. Changes in the extracellular matrix (ECM), which …
important role in cancer development. Changes in the extracellular matrix (ECM), which …
[HTML][HTML] Collagen biomarkers quantify fibroblast activity in vitro and predict survival in patients with pancreatic ductal adenocarcinoma
NI Nissen, AZ Johansen, I Chen, JS Johansen… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. New
tools which can aid in the understanding of PDAC biology and novel drug development are …
tools which can aid in the understanding of PDAC biology and novel drug development are …
The biological foundations of sarcopenia: established and promising markers
Sarcopenia, the progressive loss of muscle mass and strength, is one of the major health
issues in older adults, given its high prevalence accompanied by huge clinical and …
issues in older adults, given its high prevalence accompanied by huge clinical and …